Nasal Cavity and Paranasal Sinuses Metastasis

S RuggeriCarlos, Acosta Lautaro, P. Valentina, Serrano Candelaria
{"title":"Nasal Cavity and Paranasal Sinuses Metastasis","authors":"S RuggeriCarlos, Acosta Lautaro, P. Valentina, Serrano Candelaria","doi":"10.23937/2378-3419/1410143","DOIUrl":null,"url":null,"abstract":"Introduction: Metastasis in the nasal cavity and paranasal sinuses are rare. The most common tumor that produces them is clear cell renal carcinoma. The objective of the study is to determine the incidence of metastases in the nasal cavity and paranasal sinuses among malignant rhinosinusal tumors in our patient poblation and survival after rhinosinusal metastasis treatment. Methods: The medical records of all patients who had malignant rhinosinusal tumors diagnosed and treated in the hospital Italiano of Buenos Aires from 1989 to 2019 were retrospectively reviewed. Patients who had metastases of primary neoplasms located outside the head were selected. Results: 67 patients with malignant tumors located in the nasal cavity and paranasal sinuses were diagnosed and treated. Eight patients had metastases in the nasal cavity and paranasal sinuses. All the patients at the time the metastasis was diagnosed had a controlled primary neoplasm. The treatments indicated were: Endonasal surgery with endoscopes with complete resection of the metastasis (3/8), radiotherapy (4/8), and chemo/radiotherapy (1/8). Only two patients who died from systemic metastases had persistent tumor in the paranasal sinuses (25%). Survival at one and two years was 75% and 25% respectively. Conclusions: The incidence of metastasis in the nasal cavity and paranasal sinuses among malignant neoplasms of the rhinosinusal region was 11.94%. Survival was poor, but the performed treatments had a high rate of local control and improved the quality of life of the patients.","PeriodicalId":13873,"journal":{"name":"International journal of cancer and clinical research","volume":"124 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cancer and clinical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2378-3419/1410143","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction: Metastasis in the nasal cavity and paranasal sinuses are rare. The most common tumor that produces them is clear cell renal carcinoma. The objective of the study is to determine the incidence of metastases in the nasal cavity and paranasal sinuses among malignant rhinosinusal tumors in our patient poblation and survival after rhinosinusal metastasis treatment. Methods: The medical records of all patients who had malignant rhinosinusal tumors diagnosed and treated in the hospital Italiano of Buenos Aires from 1989 to 2019 were retrospectively reviewed. Patients who had metastases of primary neoplasms located outside the head were selected. Results: 67 patients with malignant tumors located in the nasal cavity and paranasal sinuses were diagnosed and treated. Eight patients had metastases in the nasal cavity and paranasal sinuses. All the patients at the time the metastasis was diagnosed had a controlled primary neoplasm. The treatments indicated were: Endonasal surgery with endoscopes with complete resection of the metastasis (3/8), radiotherapy (4/8), and chemo/radiotherapy (1/8). Only two patients who died from systemic metastases had persistent tumor in the paranasal sinuses (25%). Survival at one and two years was 75% and 25% respectively. Conclusions: The incidence of metastasis in the nasal cavity and paranasal sinuses among malignant neoplasms of the rhinosinusal region was 11.94%. Survival was poor, but the performed treatments had a high rate of local control and improved the quality of life of the patients.
鼻腔及鼻窦转移
在鼻腔和鼻窦转移是罕见的。最常见的肿瘤是透明细胞肾癌。本研究的目的是确定鼻鼻恶性肿瘤中鼻腔和鼻窦转移的发生率,以及鼻鼻转移治疗后的患者生存率。方法:回顾性分析1989 - 2019年在布宜诺斯艾利斯市意大利医院诊治的所有鼻鼻恶性肿瘤患者的病历。选择原发肿瘤转移至头部外的患者。结果:对67例位于鼻腔和鼻窦的恶性肿瘤进行了诊断和治疗。8例患者转移至鼻腔和鼻窦。所有确诊转移的患者原发肿瘤均得到控制。治疗方法:鼻内镜手术切除转移灶(3/8)、放疗(4/8)、化疗/放疗(1/8)。只有2例死于全身转移的患者鼻窦肿瘤持续存在(25%)。1年和2年生存率分别为75%和25%。结论:鼻鼻窦区恶性肿瘤转移至鼻腔及鼻窦的发生率为11.94%。生存率低,但局部控制率高,改善了患者的生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信